They are the star couple of the pharmaceutical industry.
He is at the origin of the largest European biotech, Actelion, sold for 30 billion dollars in 2017 to the American group Johnson & Johnson.
He is one of the 100 greatest fortunes in France.
Martine and Jean-Paul Clozel are however unknown to the general public.
And they cultivate this discretion, living for more than thirty years in Switzerland, fleeing social cocktails and refusing the seats of administrators, driven by two passions: their family and science.
One rarely goes without the other.
"We talk about patients and drugs all the time!"
Says their son, Thomas Clozel, co-founder of the French unicorn Owkin, specializing in AI dedicated to health.
To discover
Taxes 2022: all about your tax return
Read also
Insomnia: with its drug, Idorsia promises a “revolution”
Martine and Jean-Paul Clozel meet on the benches of the Nancy medical school, during their first year of studies.
According to the family legend, Jean-Paul copied on Martine… They meet on Saturdays in human biology class at the science college…
This article is for subscribers only.
You have 87% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for €0.99 for the first month
I ENJOY IT
Already subscribed?
Login